Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suk See De Ravin

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Blood Advances|January 4, 2018
Gene-edited pseudogene resurrection corrects p47<sup>phox</sup>-deficient chronic granulomatous diseaseRandall K Merling, Douglas B Kuhns, Colin L Sweeney, et al.
Gene Therapy|March 13, 2021
Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repairColin L Sweeney, Mara Pavel-Dinu, Uimook Choi, et al.
Blood Advances|January 18, 2019
<i>NCF1</i> (p47<sup>phox</sup>)-deficient chronic granulomatous disease: comprehensive genetic and flow cytometric analysisDouglas B Kuhns, Amy P Hsu, David Sun, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
A novel frameshift mutation in Phosphoinositide 3-kinase regulatory subunit 1 (<i>PIK3R1</i>) causes immunodeficiency and Amyotrophic Lateral Sclerosis (ALS)Brice Calco, Colin L Sweeney, Joseph Steiner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 8, 2014
An AAVS1-targeted minigene platform for correction of iPSCs from all five types of chronic granulomatous diseaseRandall K Merling, Colin L Sweeney, Jessica Chu, et al.
Cytotherapy|October 14, 2020
MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia diseaseJulie Brault, Ronald J Meis, Linhong Li, et al.
Blood|October 18, 2012
Humans with chronic granulomatous disease maintain humoral immunologic memory despite low frequencies of circulating memory B cellsSusan Moir, Suk See De Ravin, Brian H Santich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2011
Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous diseaseSuk See De Ravin, Malliswari Challipalli, Victoria Anderson, et al.
Blood|July 10, 2010
Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexisDavid H McDermott, Suk See De Ravin, Hyun Sik Jun, et al.
Science Translational Medicine|January 13, 2017
CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous diseaseSuk See De Ravin, Linhong Li, Xiaolin Wu, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Blood Advances|January 4, 2018
Gene-edited pseudogene resurrection corrects p47<sup>phox</sup>-deficient chronic granulomatous diseaseRandall K Merling, Douglas B Kuhns, Colin L Sweeney, et al.
Gene Therapy|March 13, 2021
Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repairColin L Sweeney, Mara Pavel-Dinu, Uimook Choi, et al.
Blood Advances|January 18, 2019
<i>NCF1</i> (p47<sup>phox</sup>)-deficient chronic granulomatous disease: comprehensive genetic and flow cytometric analysisDouglas B Kuhns, Amy P Hsu, David Sun, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
A novel frameshift mutation in Phosphoinositide 3-kinase regulatory subunit 1 (<i>PIK3R1</i>) causes immunodeficiency and Amyotrophic Lateral Sclerosis (ALS)Brice Calco, Colin L Sweeney, Joseph Steiner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 8, 2014
An AAVS1-targeted minigene platform for correction of iPSCs from all five types of chronic granulomatous diseaseRandall K Merling, Colin L Sweeney, Jessica Chu, et al.
Cytotherapy|October 14, 2020
MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia diseaseJulie Brault, Ronald J Meis, Linhong Li, et al.
Blood|October 18, 2012
Humans with chronic granulomatous disease maintain humoral immunologic memory despite low frequencies of circulating memory B cellsSusan Moir, Suk See De Ravin, Brian H Santich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2011
Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous diseaseSuk See De Ravin, Malliswari Challipalli, Victoria Anderson, et al.
Blood|July 10, 2010
Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexisDavid H McDermott, Suk See De Ravin, Hyun Sik Jun, et al.
Science Translational Medicine|January 13, 2017
CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous diseaseSuk See De Ravin, Linhong Li, Xiaolin Wu, et al.
Pageof 7